U.S., March 17 -- ClinicalTrials.gov registry received information related to the study (NCT07474051) titled 'Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials' on March 11.
Brief Summary: The goal of this clinical study is to learn more about the long-term safety, effectiveness and prolonged action of patients who participated in an AvenCell-sponsored clinical trial and received treatment with AvenCell's UniCAR or RevCAR platforms.
Study Start Date: Jan. 29
Study Type: OBSERVATIONAL
Condition:
B-cell Lymphoma
Chronic Lymphocytic Leukemia
Hematologic Malignancy
AML (Acute Myelogenous Leukemia)
Prostate Cancer
Intervention:
BIOLOGICAL: UniCAR02-T (IMP) With Targeting Module TM123
No investigational product will be ...